FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067003 [Registered on: 08/05/2024] Trial Registered Prospectively
Last Modified On: 03/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   effect of vagshudhikar churna and nasaya in speech fluency disorders 
Scientific Title of Study   A Randomized clinical controlled trial on speech fluency disorders in children with combination of Anutail Nasya and Vagshudhikar Churna 
Trial Acronym  RACE 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shubhangi thakur 
Designation  Assistant professor 
Affiliation  Government Ayurved college Osmanabad  
Address  Gaganmahal B-7 Sir Pochkhanwala Road Worli Mumbai
OPD No37 Kaumarbhritya OPD Osmanabad MAHARASHTRA 413501
Osmanabad
MAHARASHTRA
400030
India 
Phone  9404622180  
Fax    
Email  shubhangikthakur@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anil B Kale 
Designation  professor 
Affiliation  GOVERNMENT AYURVED COLLEGE OSMANABAD OSMANABAD 
Address  Government Ayurved College OSMANABAD
OPD NO 37 KAUMARBHRITYA OPD OSMANABAD MAHARASHTRA 413501
Osmanabad
MAHARASHTRA
413102
India 
Phone  9822961494  
Fax    
Email  kaleanilb@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Anil B Kale 
Designation  professor 
Affiliation  GOVERNMENT AYURVED COLLEGE OSMANABAD OSMANABAD 
Address  Government Ayurved College OSMANABAD
OPD NO 37 KAUMARBHRITYA OPD OSMANABAD 413501
Osmanabad
MAHARASHTRA
413102
India 
Phone  9822961494  
Fax    
Email  kaleanilb@yahoo.co.in  
 
Source of Monetary or Material Support  
Government Ayurved college Tuljapur road Osmanabad 413501 
 
Primary Sponsor  
Name  Dr shubhangi thakur 
Address  Government Ayurved college Tuljapur Road Osmanabad 413501 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr shubhangi thakur  Government Ayurved college osmanabad  OPD NO 37 KAUMARBHRITYA OPD Government Ayurved college, Tuljapur road, Osmanabad
Osmanabad
MAHARASHTRA 
9404622180

shubhangikthakur@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Government Ayurved college Osmanabad  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  fluency speech problems 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-nasyam/ nastam, नस्यम्/ नस्तम् (Procedure Reference: KASHAYP SAHMITA, Procedure details: Purvakarma local snehan and sewdan Pradhan karma Anu tail drops in nose 2 to 4 drops in each nostrils 3 cycles for 7 days.)
(1) Medicine Name: Anu taila, Reference: kashap sahmita, Route: Nasal, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 2(drops), Frequency: od, Duration: 21 Days
2Intervention ArmDrugClassical(1) Medicine Name: Vagshudhikar Churna, Reference: Asthang Hridaya, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -madhu), Additional Information: -dosage of churna calculated as per age and weight
3Comparator Arm (Non Ayurveda)-speech therapyspeech therapy by speech therapist for three months
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  children of the age group of 2 -12 Years
Speech related problems in consequence with delayed developmental Milestones 
 
ExclusionCriteria 
Details  Suffering from sensory aphasia or dysphasia
Children suffering from cleft palate& Cleft lip or the conditions where the surgical
intervention is required
Speech disorders secondary to disorders like cerebral palsy are excluded
Speech disorders which are complicated with other systemic disorders
Children suffering from Dysphonia & Dysarthria 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 

evaluation of dysfluencies during reading and conversation by using 100 word sample method 
6 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
efectiveness of treatement and better approach towards modification of treatement on fluency disorders   12 weeks 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   23/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is randomized clinical controlled trial comparing the saftey and efficacy of  combination of vagshudhikar churna doses for patient according to age for three months with  Anu tail Nasaya 3cycles of 21 days and another group will be with only speech therapy in age 2 to 12 years of age children the primary outcome measures will be evaluation of dysfluencies during reading at 6 weeks the secondary outcome will be overall effectiveness and better approach towards the treatement of fluency disorders at 12 weeks 
Close